SPP1 and systemic lupus erythematosus: In pathologies such as rheumatoid arthritis, systemic lupus erythematosus, and chronic kidney disease, elevated levels of OPN facilitate immune cell activation and fibroblast proliferation, thereby promoting extracellular matrix deposition and fibrosis (Figure 3).